Related Experiment Video
Updated: Mar 16, 2026

06:16
mirMachine: A One-Stop Shop for Plant miRNA Annotation
Published on: May 1, 2021
3.0K
miRNA-miRNA crosstalk: from genomics to phenomics
Briefings in Bioinformatics
|August 24, 2016
Summary
MicroRNA (miRNA)-miRNA crosstalk is key to understanding gene regulation. This review covers methods for modeling these networks, integrating diverse data for context-specific insights.
Area of Science:
- Genomics and Molecular Biology
- Bioinformatics and Computational Biology
Background:
- MicroRNA (miRNA)-miRNA crosstalk significantly advances understanding of gene regulatory networks in health and disease.
- Existing network modeling approaches utilize genomic sequences, miRNA-mRNA interactions, functional data, or phenomics, often integrating heterogeneous data types.
Purpose of the Study:
- To review and summarize state-of-the-art methods for modeling miRNA-miRNA networks.
- To highlight the importance of integrating heterogeneous omics data for accurate network construction.
- To discuss context-specific network modeling, considering tissue and disease variations.
Main Methods:
- Review of existing literature on miRNA-miRNA network modeling.
- Analysis of approaches integrating genomic, transcriptomic, functional, and phenomic data.
- Focus on methods for constructing context-specific networks.
Main Results:
- A comprehensive overview of diverse miRNA-miRNA network modeling strategies is presented.
- The necessity of integrating multiple omics data types for robust network inference is emphasized.
- The review covers methods ranging from genomics to phenomics.
Conclusions:
- Integrating heterogeneous omics data is crucial for accurate miRNA-miRNA network modeling.
- Context-specific network construction is essential for understanding disease mechanisms and tissue-specific regulation.
- Future research should explore advanced integration strategies and noncoding RNA crosstalk.
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
73
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
73
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
94
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
94
Genomics
41.5K
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
41.5K
MicroRNAs
4.2K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs
24.5K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.5K
MicroRNAs
12.0K
12.0K

